Evrofarma SA / Fundamentals
Income statement
- Net revenue
€70.92M - Cost of goods sold
€59.19M - Gross profit
€11.73M - SG&A expenses
€6.39M - R&D expenses
€160.00K - EBITDA
€8.11M - D&A
€2.62M - EBIT
€6.04M - Interest expenses
€1.19M - EBT
€3.81M - Tax expenses
€741.00K - Net income
€3.07M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€337.00K - Changes in working capital
€3.62M - Operating cash flow
€8.99M - Capex
€3.00M - Other investing cash flow
€2.29M - Net investing cash flow
-€777.00K - Total cash dividends paid
-€680.00K - Issuance of common stock
€0.00 - Debt repayment
-€197.00K - Other financing cash flow
-€6.04M - Net financing cash flow
-€6.92M - Foreign exchange effects
€0.00 - Net change in cash
-€3.93M - Cash at end of period
€3.32M - Free cash flow
€12.00M
Balance sheet
- Cash and cash equivalents
€3.32M - Cash and short-term investments
€3.32M - Total receivables
€7.37M - Inventory
€7.11M - Other current assets
€0.00 - Total current assets
€17.80M - Property, plant & equipment
€29.71M - Goodwill
€0.00 - Intangible assets
€131.00K - Long-term investments
€596.00K - Other non-current assets
€0.00 - Total non-current assets
€30.44M - Total assets
€48.24M - Accounts payable
€5.32M - Short-term debt
€11.59M - Other current liabilities
€1.35M - Total current liabilities
€18.26M - Long-term debt
€5.30M - Deferred tax liabilities
€1.04M - Other non-current liabilities
€82.00K - Total non-current liabilities
€6.42M - Total liabilities
€24.68M - Common stock
€5.74M - Retained earnings
€8.46M - Other equity
€3.62M - Total equity
€17.83M - Total liabilities and shareholders' equity
€48.24M
Company information
- Market capitalization
€27.35M - Employees
166 - Enterprise Value
€41.73M
Company ratios
- Gross margin
-
16.5% Worse than peer group: 31.9% - EBITDA margin
-
11.4% Worse than peer group: 18.2% - EBIT margin
-
8.5% Even with peer group: 12.9% - EBT margin
-
5.4% Even with peer group: 9.0% - Net margin
-
4.3% Even with peer group: 6.6% - ROE
-
17.2% Much worse than peer group: 66.5% - ROA
-
6.4% Even with peer group: 3.0% - Asset turnover
-
147.0% Much better than peer group: 78.4% - FCF margin
-
8.4% Even with peer group: 3.5% - FCF yield
21.9% - Efficiency ratio
88.6% - Net sales per employee
-
€427.22K - Net income per employee
-
€18.47K